08:00 , Nov 2, 2015 |  BioCentury  |  Finance

Expansion capital

GHO Capital expects the common thread among its private equity deals will be healthcare companies that want to grow a nascent revenue stream by geographic expansion in Europe. The firm plans to make eight or...
07:00 , Jul 1, 2013 |  BC Week In Review  |  Company News

Rapid Micro Biosystems board of directors update

Rapid Micro Biosystems Inc. , Bedford, Mass.   Business: Supply/Service   Appointed: Mark Braganza, principal at TPG Biotech; and David Hirsch, managing director at Longitude Capital  ...
00:45 , Jun 27, 2013 |  BC Extra  |  Financial News

Rapid Micro raises $32.6 million in B round

Rapid Micro Biosystems Inc. (Bedford, Mass.) raised $32.6 million in a series B round co-led by Longitude Capital and TPG Biotech. Existing investors Kleiner Perkins Caufield & Byers; TVM Capital; and Quaker Partners also participated....
08:00 , Jan 23, 2012 |  BC Week In Review  |  Financial News

Clavis completes private placement

Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway   Business: Drug delivery, Cancer, Infectious   Date completed: 1/18/12   Type: Private placement   Raised: NOK163.1 million ($26.9 million)   Shares: 2.9 million   Price: NOK57   Shares...
08:00 , Jan 11, 2010 |  BC Week In Review  |  Financial News

Affitech financial update

Affitech secured a bridge loan facility from Braganza A/S, Ferd A/S and Verdane Private Equity A/S for up to DKK9.3 million ($1.8 million). The loan bears monthly interest of 2%. Affitech A/S (CSE:AFFI), Horsolm, Denmark...
07:00 , Jul 6, 2009 |  BC Week In Review  |  Financial News

Affitech completes private placement

Affitech A/S (CSE:AFFI), Oslo, Norway   Business: Antibodies   Date completed: 7/2/09   Type: Private placement   Raised: DKK26.8 million ($5 million)   Shares: 34.4 million   Shares after offering: 227.5 million   Investors: Ferd...
07:00 , Jun 29, 2009 |  BC Week In Review  |  Financial News

Clavis completes private placement

Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway   Business: Drug delivery, Cancer, Infectious   Date completed: 6/26/09   Type: Private placement   Raised: NOK129 million ($20.1 million)   Shares: 10.8 million   Price: NOK12   Shares...
01:45 , Jun 27, 2009 |  BC Extra  |  Financial News

Clavis raises $20.1 million

Clavis Pharma ASA (OSE:CLAVIS) raised NOK129 million ($20.1 million) in a private placement of 10.8 million shares at NOK12 per share. The price is a 4% discount to Clavis' close of NOK12.50 on Thursday, before...
00:24 , Apr 11, 2006 |  BC Extra  |  Financial News

Affitech raises $13.1 million

Affitech (Oslo, Norway) raised NOK86 million ($13.1 million) in a private round. New investor Arendals Fossekompani joined existing investors Teknoinvest; Ferd; Four Seasons; and Braganza. The company has six antibodies in preclinical development for cancer....